Adsorption of mycophenolic acid and its phenolic glucuronide to glass, polystyrene, and polypropylene containers [10]

Clinical Chemistry

Volumn 52, Issue 5, 2006, Pages 904-906

  Cussonneau, Xavier ^a   Bolon Larger, Magali ^a,b   Boulieu, Roselyne ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTIN; GLASS; GLUCURONIDE; MYCOPHENOLIC ACID; PHENOL DERIVATIVE; POLYPROPYLENE; POLYSTYRENE; SOLVENT;

ADSORPTION; DEVICE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LETTER; ONLINE SYSTEM; SURFACE PROPERTY;

ADSORPTION; DRUG PACKAGING; GLASS; GLUCURONIDES; MYCOPHENOLIC ACID; POLYPROPYLENES; POLYSTYRENES; SOLVENTS; TIME FACTORS;

EID: 33646375452     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.065276     Document Type: Letter

References (10)

1. Bolon M, Jeanpierre L, El Barkil M, Chelbi K, Sauviat M, Boulieu R. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material. J Pharm Biomed Anal 2004;36:649-51.
2. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil [Review]. Clin Pharmacokinet 1998;34:429-55.
3. Shipkova M, Niedmann PD, Armstrong VW, Schutz E, Wieland E, Shaw LM, et al. Simultaneous determination of mycophenolic acid and its glucuronlde in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem 1998;44:1481-8.
4. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem 2004;50:152-9.
5. Jain A, Venkataramanan R, Hamad IS, Zuckerman S, Zhang S, Lever J, et al. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol 2001;41:268-76.
6. Mandla R, Line PD, Midtvedt K, Bergan S. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit 2003;25:407-14.
7. Aresta A, Palmisano F, Zambonin CG, Schena P, Grandaliano G. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:197-202.
8. Shen J, Jiao Z, Yu YQ, Zhang M, Zhong MK. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005;817:207-13.
9. Morgera S, Budde K, Lampe D, Ahnert V, Fritsche L, Kuchinke S, et al. Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis. Transplant Int 1998;11:53-7.
10. Yau WP, Vathsala A, Lou HX, Chan E. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. J Chromatogr B 2004;805:101-12.